PrimeRFP
PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26127P0001Eo 14398 contingency hazardous compounding — Optum Infusion Services 308, LLC

Optum Infusion Services 308, LLC holds $3.6M across 17 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. Recompete timing centers on the Sep 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

261-Network Contract Office 21 (36C261)
Awarding office
Optum Infusion Services 308, LLC
Recipient
Sep 30, 2027
PoP end
$350K
Obligated
$350K
Potential
325412
NAICS
6505
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number36C26127P0001
Also listed as36C261-27-P-0001
Agency261-Network Contract Office 21 (36C261)
Awarding office261-Network Contract Office 21 (36C261)
Awarding agencyDepartment of Veterans Affairs (VA)
Funding agencyDepartment of Veterans Affairs (VA)
IncumbentOptum Infusion Services 308, LLC
CAGE9HGM2
UEIRN5UVE9XMJN4
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Place of performanceCHANDLER AZ
Pricing typeFirm Fixed Price
Extent competedCompeted Under SAP
Related solicitation36C26126Q0485
PoP startOct 1, 2026
PoP end (current)Sep 30, 2027
Obligated$350K
Current value$350K
Potential value$350K

Eo 14398 Contingency Hazardous Compounding is a federal Unrestricted award for 261-Network Contract Office 21 (36C261) held by Optum Infusion Services 308, LLC. Estimated value $350K ($350K obligated). Current period of performance ends Sep 30, 2027. Last award drew 1 bidder. Place of performance: CHANDLER AZ. Related solicitation 36C26126Q0485.

Eo 14398 contingency hazardous compounding

Recompete timing

Public
● Expiring in 348 days

Current PoP ends Sep 30, 2027 (348 days remaining). Agencies typically plan 12–18 months ahead — at 11.4 months out, that window is already open. The buying decision is likely already in motion.

Want the durability read on 36C26127P0001? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Optum Infusion Services 308, LLC — $3.6M obligated across 17 awards (firm-wide, all agencies).

Sole agency: Department of Veterans Affairs (VA)
Department of Veterans Affairs (VA)$3.6M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
36C25726N0093
AMARILLO VA PHARMACY COMPOUNDING FOR ONCOLOGY MEDICATIONS
$225K
Oct 31, 2026
36C25626N0560
CONTINGENCY MEDICATION COMPOUNDING SERVICES - EO 14398
$500K
May 6, 2027
36C24226N0667
CHEMOCOMPOUNDING FOR TOMS RIVER
$114K
Aug 31, 2027
36C24227N0114
CHEMO COMPOUNDING - EAST ORANGE
$1.9M
Sep 30, 2027
36C25627N0017
EO 14398 503A PHARMACEUTICAL DRUG COMPOUNDING SERVICES
$300K
Sep 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 36C26127P0001?

36C26127P0001 (Eo 14398 contingency hazardous compounding) is a 261-Network Contract Office 21 (36C261) award with a potential value of $350K, currently held by Optum Infusion Services 308, LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C261-27-P-0001?

36C261-27-P-0001 is the dashed form of PIID 36C26127P0001 (Eo 14398 contingency hazardous compounding), held by Optum Infusion Services 308, LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26127P0001?

261-Network Contract Office 21 (36C261) awarded 36C26127P0001 to Optum Infusion Services 308, LLC (potential $350K).

Who is the incumbent on 36C26127P0001?

Optum Infusion Services 308, LLC is the incumbent with $3.6M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2027.

When does Optum Infusion Services 308, LLC’s 36C26127P0001 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C26127P0001? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/36C26127P0001